medical automation Market : Global Key Players are - Koninklijke Philips N.V., Siemens AG, GENERAL ELECTRIC, Medtronic, Stryker, Danaher, Accuray Incorporated

The increasing global burden of diseases like cancer, diabetes and others have increased the demands for correct and timely diagnostics, so as to be followed by accurate therapeutics. For instance, in 2016, according to the National Cancer Institute, approximately 1,685,210 new cases of cancer were diagnosed in the United States and approximately 595,690 deaths were reported due to the same. The U.S. is the largest market for biopharmaceuticals and accounts for one third of the global market. Moreover, it is estimated that the U.S. biopharmaceutical sector accounts around 17% of all domestic R&D funded by the U.S. businesses and added an estimated USD 1.2 trillion in economic output of 2014 this has led to the expansion and indulgence of various advanced paradigms of the technology in the medical sector, resulting in its automation.

The medical automation market has been on the rise over the past few years. Based on the MRFR analysis, the market is projected to reach USD 42,284.6 million by 2023 at a healthy CAGR of around 7.00%. The global market was valued at USD 26,332.7 million in 2016. The global market for medical automation is expected to grow at an exponential rate owing to the growing biotechnology and pharmaceutical sector and rising demands for robotic surgery. Majority of market players are focusing on the development of new products and product expansion in the emerging markets.

Get a sample report at https://www.marketresearchfuture.com/sample_request/5184 .

What would be the impact of the new product launches over market?

Over the last few years, the companies are focusing more toward product developments and product launch activities in order to improve the quality of the products and introduce better technology to ease the work of the healthcare professionals. Companies like Koninklijke Philips N.V., Siemens AG, and many more seems to be involved in these product launches. These launches help companies to enhance the technology and also increase the product portfolio in their list, which increase the market share and their presence around the world.

Increasing prevalence of the chronic diseases like cancer, diabetes, and others. Thus, the increasing patient population have generated demand for better treatment, which helps them to get effective outcomes. Also increasing research and developments funding’s by various public and private sectors has also lead the demands for better drugs in coming future.

Where is the market heading to?

Currently, market of medical automation cancer showing moderate growth owing to growing demands for robotic surgery and rising healthcare expenditure. Also growing pharmaceutical and biotechnology sector facilitates the automation of the medical sector. The U.S. is the largest market for biopharmaceuticals and accounts for one third of the global market. Moreover, it is estimated that the U.S. biopharmaceutical sector accounts for around 17% of all domestic R&D funded by the U.S. businesses and added an estimated USD 1.2 trillion in economic output of 2014.

Companies like Koninklijke Philips N.V., Siemens AG, GENERAL ELECTRIC, Medtronic, Stryker, Danaher, Accuray Incorporated and others are focusing on product launches, product approvals by FDA and mergers and acquisitions. For instance, In June 2017, Koninklijke Philips N.V. has acquired Electrical Geodesics a US-based medical device company that designs, develops and commercializes a range of non-invasive technologies.

Who has the ability to hinder the market growth?

With the growing advancement in the technology the costing of the products is increasing, which is has suppressed the growth of the market. For instance, According to the Economic Cycle Research Institute in 2015, the average quoted prices of da Vinci robot models was estimated to range from USD 0.91 million to USD 2.31 million.

Additionally, risks associated to the robotic surgery followed by the necessity of physician training.

Browse Complete Report at https://www.marketresearchfuture.com/reports/medical-automation-market-5184 .

Additionally, rising demands for robotic surgery and rising healthcare expenditure is boosting the market growth. In 2014, according to the Health Research Funding, in 2012 approximately 400,000 robotic surgeries were performed across all types of surgeries in the U.S. Moreover, it is suggested that blood transfusion rates during robotic surgeries are minimal as compared to the open surgery blood transfusion rates that may be up to 40%. However, the high cost of automation, risks associated with the robotic surgery along with the necessity of physician training are the major restraining factor for the market growth during the forecast period. In 2017, according to a case study published in the Journal of Public Health Research, the unified automated laboratory in Brescia called Core-Lab’s equipment cost increased approximately from USD 17.7 million to USD 24.2 million due to lab automation. Moreover, it was estimated that the physicians need a rigorous training for the surgical application of the medical robots. Approximately, USD 3,000 is the training cost per physician.

About us

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

P: +1 646 845 9312

W: www.marketresearchfuture.com

sales@marketresearchfuture.com

This release was published on openPR.